Cargando…
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
BACKGROUND: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the efficacy and safety of therapeutic versus prophylactic anticoagulation...
Ejemplares similares
-
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial()()
por: Lopes, Renato D., et al.
Publicado: (2021) -
Factors associated with mortality among elderly people hospitalized due to femoral fractures()
por: Franco, Léo Graciolli, et al.
Publicado: (2016) -
Splenic Angiosarcoma: A Diagnostic Splenectomy Finding
por: de Azevedo, Otavio Schmidt, et al.
Publicado: (2016) -
In Silico Approach for Characterization and Comparison of Repeats in the Genomes of Oil and Date Palms
por: Filho, Jaire Alves Ferreira, et al.
Publicado: (2017) -
Oligochitosan Synthesized by Cunninghamella elegans, a Fungus from Caatinga (The Brazilian Savanna) Is a Better Antioxidant than Animal Chitosan
por: Paiva, Weslley Souza, et al.
Publicado: (2021)